Security key
034569103
Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB)
CUSIP: 034569103
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 6,836,130
- Total 13F value
- $19,834,339
- Share change
- -210,177
- SEC-reported price per share
- $2.90
- Number of holders
- 9
- Value change
- -$508,787
- Number of buys
- 3
- Number of sells
- 4
- Shares outstanding
- 41,587,315
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
9
Top holders
9
ANEB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2023
Previous quarter: Q4 2022
Anebulo Pharmaceuticals, Inc. SEC filings
Anebulo Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 034569103
Recent filing periods:
Ownership snapshot
Top reported holders of ANEB - Anebulo Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
22NW, LP
Disclosed value leader
22NW, LP
Comparable rows
12/14
Latest evidence
31 Dec 2022
13F
3/4/5
Lead comparable stake: 12%
2 rows are not safely comparable across share classes.
Showing 1-6 of 14 holder rows.
Quick read
22NW, LP leads the comparable SEC ownership view at 12%.
12 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens 22NW, LP's linked filing trail.
Comparable ownership
Top 5
22NW, LP
12%
LVW Advisors, LLC
1.6%
Nantahala Capital Management, LLC
1.2%
MANGROVE PARTNERS IM, LLC
0.96%
Praetorian Capital Management LLC
0.43%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 14 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| 22NW, LP |
13F
Company
|
12%
|
$12,279,167
5,066,290 shares
|
— | 31 Dec 2022 |
| LVW Advisors, LLC |
13F
Company
|
1.6%
|
$1,633,365
673,914 shares
|
— | 31 Dec 2022 |
| Nantahala Capital Management, LLC |
13F
Company
|
1.2%
|
$1,238,688
511,073 shares
|
— | 31 Dec 2022 |
| MANGROVE PARTNERS IM, LLC |
13F
Company
|
0.96%
|
$967,587
399,219 shares
|
— | 31 Dec 2022 |
| Praetorian Capital Management LLC |
13F
Company
|
0.43%
|
$436,278
180,005 shares
|
— | 31 Dec 2022 |
| Ikarian Capital, LLC |
13F
Company
|
0.38%
|
$374,888
156,203 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
9
Shares
6,836,130
Rows available
9
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
12
Q1 2023 holders
9
Holder diff
-3
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend